Primary sclerosing cholangitis: refinement and validation of survival models

Autor: Dickson, ER, Murtaugh, PA, Wiesner, RH, Grambsch, PM, Fleming, TR, Ludwig, J, LaRusso, NF, Malinchoc, M, Chapman, RW, Kaplan, MM

The natural history of primary sclerosing cholangitis was studied in 426 patients from five medical centers. The median follow-up time was 3.0 years (range, 0.01-16.6 years); 100 patients had died by the time of last follow-up. Survival analysis (Cox

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6723e2f4932fa3310082480917e0c2ec
https://ora.ox.ac.uk/objects/uuid:1aaace6d-6f87-41a6-a666-ff9eb1cef622

Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival

Autor: Benza RL, Barst RJ, Frost A, Girgis RE, Highland KB, Strange C, Black CM, Badesch DB, Rubin L, Fleming TR, Naeije R., GALIE', NAZZARENO

Publikováno v: Chest. 134(4)

Despite advances in the management of pulmonary arterial hypertension (PAH), the mortality rate remains excessive. Long-term efficacy evaluations are needed to guide therapeutic management. The purpose of this study is to present 1-year observational

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a9de5ff55183782efbb754306107adc8
https://pubmed.ncbi.nlm.nih.gov/18625676

Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study

Autor: Tavel, JA, Babiker, A, Carey, C, Fisher, M, Fox, L, Gey, D, Lopardo, GD, Lopez, JC, Markowitz, N, Munroe, D, Paton, N, Ruxrungtham, K, Standridge, B, Wentworth, D, Wyman, N, Aagaard, B, Borup, L, Grarup, J, Jansson, PO, Jensen, K, Lundgren, J, Mollerup, D, Reilev, S, Braimah, N, Darbyshire, J, Horton, J, King, E, Smith, N, Van Hooff, F, Cooper, DA, Courtney-Rodgers, D, Emery, S, Finley, E, Gordin, F, Sánchez, A, Thomas, D, Bebchuk, J, Bollenbeck, P, Denning, E, DuChene, AG, Fosdick, L, Harrison, M, Krum, E, Larson, G, Neaton, JD, Nelson, R, Quan, K, Quan, SFL, Schultz, T, Thompson, G, Collins, S, Haerry, DH, Meulbroek, M, Peavy, D, Rappoport, C, Schwarze, S, Valdez, M, Watson, J, Belloso, WH, Davey, R, Duprez, D, Gatell, JM, Hoy, J, Lifson, A, Pederson, C, Perez, G, Price, R, Prineas, R, Rhame, F, Sampson, JH, Worley, J, Modlin, JF, Beral, V, Chaisson, RE, Fleming, TR, Hill, C, Kim, KM, Murray, BE, Pick, B, Seligmann, M, Weller, I, Luzar, MA, Martinez, A, Costas, V

Publikováno v: Tavel, JA; Babiker, A; Carey, C; Fisher, M; Fox, L; Gey, D; et al.(2010). Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study. PLoS ONE, 5(2). doi: 10.1371/journal.pone.0009334. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1b66v2rs

Background: The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4+ counts compared to no therapy. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::6d497140209e5630bf7d75b6950ca8f7
http://www.escholarship.org/uc/item/1b66v2rs

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.